PUBLIC COMPANY
save$BCABBioAtla, Inc.
$BCABSan Diego, CA, USupdated 2mo ago
community read0 votes
pipeline
5
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Preclinical4Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- phase2CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
- phase1Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
- phase2CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
- phase2A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
- phase2CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 11, 26grantSHORT JAY M PHD · Chief Executive Officer430,000 sh
- Mar 10, 26grantSievers Eric · Chief Medical Officer240,000 sh
- Mar 10, 26grantVasquez Christian · Chief Financial Officer240,000 sh
- Feb 28, 26tax coverSHORT JAY M PHD · Chief Executive Officer7,728 sh
- Feb 28, 26tax coverSievers Eric · Chief Medical Officer3,140 sh
- Feb 28, 26tax coverWALDRON RICHARD A · Former Chief Financial Officer2,729 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that